Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.

@article{Ebbo2014UsefulnessO2,
  title={Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.},
  author={Mikael Ebbo and Aur{\'e}lie Grados and Eric Guedj and Delphine Gobert and C{\'e}cile Colavolpe and Mohamad Zaidan and Agathe Masseau and Fanny Bernard and J Y Berthelot and Nathalie Morel and François Lifermann and Sylvain Palat and Julien Haroche and Xavier Mariette and Bertrand Godeau and Emmanuelle Bernit and Nathalie Cost{\'e}doat-Chalumeau and Thomas Papo and Mohamed Amine Hamidou and Jean-Robert Harl{\'e} and Nicolas Schleinitz},
  journal={Arthritis care & research},
  year={2014},
  volume={66 1},
  pages={86-96}
}
OBJECTIVE To evaluate the usefulness of 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in IgG4-related disease (IgG4-RD) for the staging of the disease and the followup under treatment. METHODS All patients included in the French IgG4-RD registry who underwent ≥1 FDG-PET/CT scan were included in the study. Clinical, biologic, pathologic, radiologic, and FDG-PET/CT qualitative and quantitative findings were retrospectively collected and analyzed… CONTINUE READING